Akorn Relaunches Ofloxacin Otic Solution
25 août 2016 08h30 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Aug. 25, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has relaunched Ofloxacin Otic Solution 0.3%, a...
Akorn to Present at Morgan Stanley Global Healthcare Conference
24 août 2016 08h30 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Aug. 24, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Akorn’s CEO, Raj Rai, will participate in a...
Akorn Appoints Robert Monahan as Senior Vice President of Corporate Development
18 août 2016 08h30 HE
|
Akorn, Inc.
LAKE FOREST, Ill., Aug. 18, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that Rob Monahan has recently joined Akorn as...
Akorn Provides Second Quarter 2016 Results
04 août 2016 07h00 HE
|
Akorn, Inc.
- Q2 2016 Revenue Increase of 27% to $281 Million -- Q2 2016 GAAP EPS Increase of 85% to $0.50; Adjusted Q2 2016 EPS Increase of 41% to $0.58 -- Updates 2016 Revenue and EPS Guidance -- Board of...
Akorn Announces Second Quarter 2016 Earnings Release and Conference Call Information
21 juil. 2016 08h05 HE
|
Akorn, Inc.
LAKE FOREST, Ill., July 21, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it plans to issue a press release on...
Akorn Updates Form S-8 Status by Filing Form 10-Q’s for First, Second and Third Quarters of 2015
02 juin 2016 06h30 HE
|
Akorn, Inc.
LAKE FOREST, Ill., June 02, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that it has filed quarterly reports on Forms 10-Q...
Akorn to Present at Two Upcoming Investor Conferences
31 mai 2016 08h30 HE
|
Akorn, Inc.
LAKE FOREST, Ill., May 31, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced that management will be presenting at the Jefferies...
Akorn Provides First Quarter 2016 Results
16 mai 2016 16h42 HE
|
Akorn, Inc.
- Q1 2016 GAAP Revenue of $268 million - - GAAP EPS of $0.34; Adjusted Q1 2016 EPS of $0.54 - - Conference Call and Webcast to Be Held May 17, 2016 at 10:00 a.m. EDT - LAKE FOREST, Ill., May 16,...
Akorn Completes 2014 Financial Statement Restatement and Reports Audited 2015 and Restated 2014 Results
10 mai 2016 06h44 HE
|
Akorn, Inc.
- Sets Date for 2016 Annual Meeting - Affirms 2016 Net Revenue and Earnings per Share Guidance LAKE FOREST, Ill., May 10, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty...
Akorn Outlines Timeline for 2015 Form 10-K Filing, First Quarter 2016 Form 10-Q Filing and Investor Conference Calls
06 mai 2016 14h50 HE
|
Akorn, Inc.
LAKE FOREST, Ill., May 06, 2016 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty generic pharmaceutical company, today announced the target dates for upcoming filings and press...